Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Table of Contents: Oncotarget’s Volume 12, Issue #19

Oncotarget

September 14, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 19. continue reading »

New Study: How Exercise Boosted Chemotherapy in Mice

Oncotarget

September 1, 2021
A 2021 study demonstrated how exercise impacts a highly-prescribed chemotherapeutic agent, doxorubicin, in murine models of breast cancer. continue reading »

Table of Contents: Oncotarget’s Volume 12, Issue #18

Oncotarget

August 31, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 18. continue reading »

Behind the Study: Oral Squamous Carcinoma Cell Migration and Viability

Oncotarget

August 30, 2021
Dr. Gary S. Goldberg from Rowan University details a 2015 paper he co-authored, entitled, “Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.” continue reading »

Trending With Impact: Promising Non-Small Cell Lung Cancer Prodrug

Oncotarget

August 26, 2021
Researchers examined the preclinical prodrug LP-184 and its efficacy in treating non-small cell lung cancers that lack actionable targets or resistance-related genes. continue reading »